Page 5 - Torrent Pharma

Torrent Pharma Q2 net profit declines marginally to Rs 312 crore

Torrent Pharmaceuticals on Friday reported a marginal decline in its consolidated net profit at Rs 312 crore for the second quarter ended September 2022. The company had posted a consolidated net profit of Rs 316 crore in the year-ago period. Revenue from operations rose to Rs 2,291 crore in the July-September quarter as against Rs 2,137 crore in the year-ago period, Torrent Pharma said in a statement. The company said its domestic revenue stood at Rs 1,224 crore during the period under review. The drug firm also reported robust sales across various international markets like the US, and Brazil, it added. Shares of the company on Friday ended 0.99 per cent down at Rs 1,578 apiece on the BSE.

Stocks to Watch: Nykaa, Ramco Cements, Blue Dart, Zomato, Torrent Pharma

Stock to watch today: Nykaa's board meeting will be held on October, 3 to consider and approve the issuance of bonus shares

Torrent Pharma to acquire Curatio Healthcare for Rs 2,000 cr; stock down 6%

ICICI Securities is positive on Torrent's ability of faster integration and turnaround of acquired assets in the domestic space

Torrent Pharma acquires cosmetic derma player Curatio for Rs 2,000 cr

First major acquisition by Aman Mehta after taking charge at Torrent Pharma in August

Indian generic formulation-makers level of capex declining: Candle Partners

Candle Partners study shows that from the peak of 30% of gross block in FY16, the capex is down to 9-10% of gross block

Torrent group to make Rs 2,900-cr bid for Reliance Nippon Life Insurance

Reliance Capital is undergoing a bankruptcy process and the administrator had sought offers for the entire company and for its various business clusters

Sensex, Nifty end flat post lackluster trade; Syrma soars 42%, Titan 3%

CLOSING BELL: It was a range-bound trade on the bourses on Friday as investors awaited US Fed chief Jerome Powell's address at the Jackson Hole Symposium later tonight

Stocks to watch: Titan, Dr Reddy's, Nelco, IOC, GIC Housing, Torrent Pharma

Stocks to watch today: Titan plans to add 20 to 30 Tanishq stores over two to three years in the Middle East and North America; Nelco inked pact with Intelsat to provide inflight connectivity services

Rise of cosmetic dermatology space gets big pharma looking for buyouts

According to reports, Torrent Pharmaceuticals is set to sign a deal to acquire Curatio Healthcare, a maker of skincare products, for Rs 2100 crore.

Ceat, Ambuja, IRCTC among 30 stocks that can defy current market volatility

Ambuja Cements, Ceat, Eicher Motors, Pidilite Industries, Tata Chemicals, Torrent Power and Wockhardt are few of the prominent stocks holding on to the bullish outlook.

Torrent group rolls out succession plan; Aman Mehta joins pharma unit board

Last year, Aman had told Business Standard that they were still quite flexible to take up roles within the organisation

Torrent Pharma expected to enter diagnostics space in next 2-3 months

A company called Torrent Diagnostics Private Ltd was incorporated in February this year and has a Torrent Pharmaceuticals executive director as one of its directors

Nifty can target 16,650 in the short-term, says Vinay Rajani

The technical analyst from HDFC Securities also recommends buying CCL Products and Torrent Pharma.

Strong domestic outlook remains key growth driver for Torrent Pharma

Cost savings could drive Torrent Pharma's margins higher in the near term

Torrent Pharma's domestic show remains strong, brokerages turn positive

Progress on US sales will be key for further Torrent Pharma's stock gains

Stocks to Watch: RIL, HUL, Dr.Reddy's, PNB Housing, Future Retail, Banks

Reliance Industries is likely to be in limelight as the company is looking to take advantage of the surging diesel demand in Europe in the backdrop of Russia-Ukraine conflict.

Sensex slips 581 pts amid hawkish US Fed, F&O expiry; Nifty holds 17,100

Sectorally, the Nifty PSU Bank index jumped a massive 5 per cent on the NSE, while the Nifty Bank and Private Bank indices added about a per cent each

Torrent Pharma tumbles 14% on disappointing Q3 results

In Q3FY22, earnings before interest tax and depreciation and amortization (EBITDA) margins declined 490 bps YoY to 25.5 per cent driven by price erosion in the US.

Torrent Pharma net profit drops 16% to Rs 249 crore in third quarter

The company's revenue from operations in the third quarter stood at Rs 2,108 crore as compared to Rs 1,995 crore in the same period of previous fiscal

Sensex snaps 5-day losing run, ends 367 pts up; Nifty holds 17,250

Bargain buying in banking and auto counters amid better-than-expected Q3 results by Axis Bank and Maruti Suzuki pushed the index 367 points higher at 57,858 level at close